A CU research team will receive a $2 million funding grant from the Patient-Centered Outcomes Research Institute to study offering palliative care to patients with Parkinson’s disease.
CU researchers say a clinical study on children shows promise for a vaccine that could prevent type 1 diabetes.
The incidence of a potentially life-threatening complication of diabetes increased by 55 percent between 1998 and 2012 in Colorado youth, a CU study shows.
Confused about all the conflicting cholesterol reports? You're not alone, a CU researcher says.
An Indian company that has developed a genetic sequencing test that analyzes cancer tumors and provides potential treatment options has moved its U.S. headquarters next to campus.
The new Gates Biomanufacturing Facility will accelerate scientific discoveries to reach patients quicker.
A CU professor says Burning Mouth Syndrome is common in postmenopausal women and can have different causes.
A $1.5 million gift from the Connor Family Foundation will help CU researchers find treatments for young women with breast cancer.
A team from the Anschutz Medical Campus won the top prize in the Innovations Competition at the Society of Hospital Medicine meeting in Washington, D.C., in late March.
Brain activity affects the way the developing brain connects neurons, and a study by CU researchers suggests a new model for understanding that process.
CU scientists have discovered a gene mutation that increases the risk of acute lymphoblastic leukemia.
John Kappler, PhD, has been named Interim Scientific Director of the Barbara Davis Center for Childhood Diabetes n the School of Medicine.
Many patients with psoriasis notice fewer symptoms following a tonsillectomy.
Coordinating patient care between hospitals and primary-care physicians is a significant challenge due to poor communication and gaps in information-sharing strategies, CU research shows.
CU physicians are helping cancer patients live longer through experimental, personalized therapies.